BBNX
Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) has 17 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 2, 2026.
The most active filer is Chief Financial Officer Feider Stephen with 3 filings. Insiders have net sold $767K over the trailing 6 months.
- Industry:Medical - Equipment & Services
- CEO:Sean T. Saint
- Employees:352
- HQ:Irvine, CA, US
- IPO:2025-01-30
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$767K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$770.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Sale | 5,104 | $87K | Jul 2 | SEC ↗ | |
| Chief Financial Officer | Sale | 4,896 | $83K | Jul 2 | SEC ↗ | |
| Director | Sale | 1,406 | $21K | Jun 25 | SEC ↗ | |
| Chief Commercial Officer | Sale | 1,258 | $19K | Jun 25 | SEC ↗ | |
| Chief Commercial Officer | Sale | 275 | $3K | Jun 5 | SEC ↗ | |
| Director | Sale | 2,811 | $39K | Jun 5 | SEC ↗ | |
Mensinger MikeFirst filing | Chief Product Officer | Sale | 4,378 | $55K | Jun 3 | SEC ↗ |
Hopman MarkFirst filing | Chief Commercial Officer | Sale | 5,329 | $67K | Jun 3 | SEC ↗ |
Saint SeanFirst filing | President & CEO | Sale | 16,872 | $213K | Jun 3 | SEC ↗ |
Russell Steven JonFirst filing | Chief Medical Officer | Sale | 4,222 | $53K | Jun 3 | SEC ↗ |
Feider StephenFirst filing | Chief Financial Officer | Sale | 6,676 | $84K | Jun 3 | SEC ↗ |
Jones ChristyFirst filing | Director | Sale | 1,998 | $20K | May 26 | SEC ↗ |
Lezack AdamFirst filing | Director | Sale | 1,000 | $10K | May 26 | SEC ↗ |
Lezack AdamFirst filing | Director | Sale | 998 | $11K | May 26 | SEC ↗ |
Related companies
Beta Bionics, Inc. is in the Healthcare sector.